Evolution of cancer stem cells

Seminars in Cancer Biology

Volumn 17, Issue 3, 2007, Pages 204-213

  Bapat, S A ^a  

^a NATIONAL CENTRE FOR CELL SCIENCE   (India)

Author keywords

Cancer stem cells; Evolution; Genome; Population

Indexed keywords

ANEUPLOIDY; CANCER STEM CELL; CELL TRANSFORMATION; CHROMATIN ASSEMBLY AND DISASSEMBLY; CHROMOSOMAL INSTABILITY; DNA METHYLATION; EPIGENETICS; EVOLUTION; GENE MUTATION; GENOME; HUMAN; REVIEW;

ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; HUMANS; NEOPLASMS; TUMOR STEM CELLS;

EID: 33947207952     PISSN: 1044579X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semcancer.2006.05.001     Document Type: Review

References (83)

1. Michor F., Iwasa Y., and Nowak M.A. Dynamics of cancer progression. Nat Rev Cancer 4 (2004) 197-205
2. Clarke M.F. Epigenetic regulation of normal and cancer stem cells. Ann NY Acad Sci 1044 (2005) 90-93
3. Bonnet D., and Dick J.E. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med 3 (1997) 730-737
4. Reya T., Morrison S.J., Clarke M.F., and Weissman I.L. Stem cells, cancer, and cancer stem cells. Nature 414 (2001) 105-111
5. Nowell P.C. The clonal evolution of tumor cell populations. Science 194 (1976) 23-28
6. Rizvi A.Z., and Wong M.H. Epithelial stem cells and their niche: there's no place like home. Stem Cells 23 (2005) 150-165
7. Beachy P.A., Karhadkar S.S., and Berman D.M. Tissue repair and stem cell renewal in carcinogenesis. Nature 432 7015 (2004) 324-331
8. Bissell M.J., and Labarge M.A. Context, tissue plasticity, and cancer: are cancer stem cells also regulated by the microenvironment?. Cancer Cell 7 1 (2005) 17-23
9. Miller S.J., Lavker R.M., and Sun T.T. Interpreting epithelial cancer biology in the context of stem cells: tumor properties and therapeutic implications. Biochim Biophys Acta 1756 (2005) 25-52
10. Lu B., Jan L., and Jan Y.N. Control of cell divisions in the nervous system: symmetry and asymmetry. Annu Rev Neurosci 23 (2000) 531-556
11. Gudjonsson T., and Magnusson M.K. Stem cell biology and the cellular pathways of carcinogenesis. APMIS 113 11/12 (2005) 922-929
12. Romano G. The role of adult stem cells in carcinogenesis. Drug News Perspect 18 (2005) 555-559
13. Wicha M.S., Liu S., and Dontu G. Cancer stem cells: an old idea-a paradigm shift. Cancer Res 66 4 (2006) 1883-1890
14. van Tilborg A.A.G., de Vries A., de Bont M., Groenfeld L.E., van der Kwast T.H., and Zwarthoff E.C. Molecular evolution of multiple recurrent cancers of the bladder. Hum Mol Gen 9 (2000) 2973-2980
15. Hahn W.C., and Weinberg R.A. Modelling the molecular circuitry of cancer. Nat Rev Cancer 2 (2002) 331-341
16. Jones P.A., and Baylin S.B. The fundamental role of epigenetic events in cancer. Nat Rev Gen 3 (2002) 415-428
17. Wilson C.B., Makar K.W., Shnyreva M., and Fitzpatrick D.R. DNA methylation and the expanding epigenetics of T cell lineage commitment. Se Immunol 17 (2005) 105-119
18. Gregory R.I., and Shiekhattar R. Chromatin modifiers and carcinogenesis. Trends Cell Biol 14 (2004) 695-702
19. Santos-Rosa H., and Caldas C. Chromatin modifier enzymes, the histone code and cancer. Eur J Cancer 41 (2005) 2381-2402
20. Moe-Behrens G.H., and Pandolfi P.P. Targeting aberrant transcriptional repression in acute myeloid leukemia. Rev Clin Exp Hematol 7 (2003) 139-159
21. Frank S.R., Parisi T., Taubert S., Fernandez P., Fuchs M., Chan H.M., et al. MYC recruits the TIP60 histone acetyltransferase complex to chromatin. EMBO Rep 4 (2003) 575-580
22. Stopka T., and Skoultchi A.I. The ISWI ATPase Snf2h is required for early mouse development. Proc Natl Acad Sci USA 100 24 (2003) 14097-14102
23. Klochendler-Yeivin A., Fiette L., Barra J., Muchardt C., Babinet C., and Yaniv M. The murine SNF5/INI1 chromatin remodeling factor is essential for embryonic development and tumor suppression. MBO Rep 1 6 (2000) 500-506
24. Vries R.G., Bezrookove V., Zuijderduijn L.M., Kia S.K., Houweling A., Oruetxebarria I., et al. Cancer-associated mutations in chromatin remodeler hSNF5 promote chromosomal instability by compromising the mitotic checkpoint. Genes Dev 19 (2005) 665-670
25. Chai B., Huang J., Cairns B.R., and Laurent B.C. Distinct roles for the RSC and Swi/Snf ATP-dependent chromatin remodelers in DNA double-strand break repair. Genes Dev 19 14 (2005) 1656-1661
26. Rosson G.B., Bartlett C., Reed W., and Weissman B.E. BRG1 loss in MiaPaCa2 cells induces an altered cellular morphology and disruption in the organization of the actin cytoskeleton. J Cell Physiol 205 (2005) 286-294
27. Banine F., Bartlett C., Gunawardena R., Muchardt C., Yaniv M., Knudsen E.S., et al. Sherman LS SWI/SNF chromatin-remodeling factors induce changes in DNA methylation to promote transcriptional activation. Cancer Res 65 (2005) 3542-3547
28. Kathrein K.L., Lorenz R., Innes A.M., Griffiths E., and Winandy S. Ikaros induces quiescence and T-cell differentiation in a leukemia cell line. Mol Cell Biol 25 (2005) 1645-1654
29. Klein F., Feldhahn N., Herzog S., Sprangers M., Mooster J.L., Jumaa H., et al. BCR-ABL1 induces aberrant splicing of IKAROS and lineage infidelity in pre-B lymphoblastic leukemia cells. Oncogene 25 (2006) 1118-1124
30. Felsher D.W. Cancer revoked: oncogenes as therapeutic targets. Nat Rev Cancer 3 (2003) 375-380
31. Liu L., Lai S., Andrews L.G., and Tollefsbol T.O. Genetic and epigenetic modulation of telomerase activity in development and disease. Gene 340 (2004) 1-10
32. Holm T.M., Jackson-Grusby L., Brambrink T., Yamada Y., Rideout III W.M., and Jaenisch R. Global loss of imprinting leads to widespread tumorigenesis in adult mice. Cancer Cell 8 (2005) 275-285
33. Viré E., Brenner C., Deplus R., Blanchon L., Fraga M., Didelot C., et al. The Polycomb group protein EZH2 directly controls DNA methylation. Nature 439 (2006) 871-874
34. Issa J.-P. Cpg island methylator phenotype in cancer. Nat Rev Can 4 (2004) 988-993
35. Gaudet F., Hodgson J.G., Eden A., Jackson-Grusby L., Dausman J., Gray J.W., et al. Induction of tumors in mice by genomic hypomethylation. Science 300 (2003) 489-492
36. Peters A.H., O'Carroll D., Scherthan H., Mechtler K., Sauer S., Schofer C., et al. Loss of the Suv39h histone methyltransferases impairs mammalian heterochromatin and genome stability. Cell 107 (2001) 323-337
37. Hochedlinger K., Blelloch R., Brennan C., Yamada Y., Kim M., Chin L., et al. Reprogramming of a melanoma genome by nuclear transplantation. Genes Dev 18 (2004) 1875-1885
38. Hochedlinger K., and Jaenisch R. Monoclonal mice generated by nuclear transfer from mature B and T donor cells. Nature 415 (2002) 1035-1038
39. Eggan K., Baldwin K., Tackett M., Osborne J., Gogos J., Chess A., et al. Mice cloned from olfactory sensory neurons. Nature 428 (2004) 44-49
40. Blelloch R.H., Hochedlinger K., Yamada Y., Brennan C., Kim M., Mintz B., et al. Nuclear cloning of embryonal carcinoma cells. Proc Natl Acad Sci USA 101 (2004) 13985-13990
41. Li L., Connelly M.C., Wetmore C., Curran T., and Morgan J.I. Mouse embryos cloned from brain tumors. Cancer Res 63 (2003) 2733-2736
42. Liu L., Zhang J., Bates S., Li J.J., Peehl D.M., Rhim J.S., et al. A methylation profile of in vitro immortalized human cell lines. Int J Oncol 26 (2005) 275-285
43. Lopatina N.G., Poole J.C., Saldanha S.N., Hansen N.J., Key J.S., Pita M.A., et al. Control mechanisms in the regulation of telomerase reverse transcriptase expression in differentiating human teratocarcinoma cells. Biochem Biophys Res Commun 306 (2003) 650-659
44. Mukhopadhyay N.K., Gordon G.J., Maulik G., Doerre G., Liu B.C., Bueno R., et al. Histone deacetylation is directly involved in desilencing the expression of the catalytic subunit of telomerase in normal lung fibroblast. J Cell Mol Med 9 (2005) 662-669
45. Kumakura S., Tsutsui T.W., Yagisawa J., Barrett J.C., and Tsutsui T. Reversible conversion of immortal human cells from telomerase-positive to telomerase-negative cells. Cancer Res 65 (2005) 2778-2786
46. Pakendorf B., and Stoneking M. Mitochondrial DNA and human evolution. Ann Rev Genomics Hum Genet 6 (2005) 165-183
47. O'Brien T.W., O'Brien B.J., and Norman R.A. Nuclear MRP genes and mitochondrial disease. Gene 354 (2005) 147-151
48. Coller H.A., Khrapko K., Bodyak N.D., Nekhaeva E., Herrero-Jimenez P., and Thilly W.G. High frequency of homoplasmic mitochondrial DNA mutations in human tumors can be explained without selection. Nat Genet 28 (2001) 147-150
49. Jeronimo C., Nomoto S., Caballero O.L., Usadel H., Henrique R., Varzim G., et al. Facile detection of mitochondrial DNA mutations in tumors and bodily fluids. Science 287 (2000) 2017-2019
50. Lee H.C., Yin P.H., Lin J.C., Wu C.C., Chen C.Y., Wu C.W., et al. Mitochondrial genome instability and mtDNA depletion in human cancers. Ann NY Acad Sci 1042 (2005) 109-122
51. Kang D., and Hamasaki N. Mitochondrial DNA in somatic cells: a promising target of routine clinical tests. Clin Biochem 38 (2005) 685-695
52. Mambo E., Chatterjee A., Xing M., Tallini G., Haugen B.R., Yeung S.C., et al. Tumor-specific changes in mtDNA content in human cancer. Int J Cancer 116 (2005) 920-924
53. Jakupciak J.P., Wang W., Markowitz M.E., Ally D., Coble M., Srivastava S., et al. Mitochondrial DNA as a cancer biomarker. J Mol Diagn 7 (2005) 258-267
54. Petros J.A., Baumann A.K., Ruiz-Pesini E., Amin M.B., Sun C.Q., Hall J., et al. mtDNA mutations increase tumorigenicity in prostate cancer. Proc Natl Acad Sci USA 102 (2005) 719-724
55. Shidara Y., Yamagata K., Kanamori T., Nakano K., Kwong J.Q., Manfredi G., et al. Positive contribution of pathogenic mutations in the mitochondrial genome to the promotion of cancer by prevention from apoptosis. Cancer Res 65 (2005) 1655-1663
56. Wani A.A., Sharma N., Shouche Y.S., and Bapat S.A. Nuclear-mitochondrial genomic profiling reveals a pattern of evolution in epithelial ovarian tumor stem cells. Oncogene 25 (2006) 6336-6344
57. Bapat S.A., Mali A.M., Koppikar C.B., and Kurrey N.K. Stem and progenitor-like cells contribute to the aggressive behavior of human epithelial ovarian cancer. Cancer Res 65 (2005) 3025-3029
58. Vanharanta S., Pollard P.J., Lehtonen H.J., Laiho P., Sjoberg J., Leen A., et al. Distinct expression profile in fumarate-hydratase-deficient uterine fibroids. Hum Mol Genet 15 (2006) 97-103
59. Schulz T.J., Thierbach R., Voigt A., Drewes G., Mietzner B.H., Steinberg P., et al. Induction of oxidative metabolism by mitochondrial frataxin inhibits cancer growth: Otto Warburg revisited. J Biol Chem 281 (2006) 977-981
60. Delsite R., Kachhap S., Anbazhagan R., Gabrielson E., and Singh K.K. Nuclear genes involved in mitochondria-to-nucleus communication in breast cancer cells. Mol Cancer 1 (2002) 6
61. Guan M.X., Fischel-Ghodsian N., and Attardi G. Nuclear background deteres biochemical phenotype in the deafness-associated mitochondrial 12S rRNA mutation. Hum Mol Genet 10 (2001) 573-580
62. Holm T.M., Jackson-Grusby L., Brambrink T., Yamada Y., Rideout III W.M., and Jaenisch R. Global loss of imprinting leads to widespread tumorigenesis in adult mice. Cancer Cell 8 (2005) 275-285
63. Meletis K., Wirta V., Hede S.M., Nister M., Lundeberg J., and Frisen J. p53 suppresses the self-renewal of adult neural stem cells. Development 133 (2006) 363-369
64. Bignold L.P., Coghlan B.L., and Jersmann H.P. Cancer morphology, carcinogenesis and genetic instability: a background. EXS 96 (2006) 1-24
65. Leedham S.J., Schier S., Thliveris A.T., Halberg R.B., Newton M.A., and Wright N.A. From gene mutations to tumours-stem cells in gastrointestinal carcinogenesis. Cell Prolif 38 (2005) 387-405
66. Frohling S., Scholl C., Gilliland D.G., and Levine R.L. Genetics of myeloid malignancies: pathogenetic and clinical implications. J Clin Oncol 23 (2005) 6285-6295
67. Boland C.R., and Goel A. Somatic evolution of cancer cells. Se Cancer Biol 15 (2005) 436-450
68. Sieber O.M., Heinimann K., and Tomlinson I.P. Genomic instability-the engine of tumorigenesis?. Nat Rev Cancer 3 (2003) 701-708
69. Nguyen HG, Ravid K. Tetraploidy/aneuploidy and stem cells in cancer promotion: the role of chromosome passenger proteins. J Cell Physiol 2005; December 5 [Epub ahead of print].
70. Yuen K.W., Montpetit B., and Hieter P. The kinetochore and cancer: what's the connection?. Curr Opin Cell Biol 17 (2005) 576-582
71. Pathak S., and Multani A.S. Aneuploidy, stem cells and cancer. EXS 96 (2006) 49-64
72. Chen E, Lim MS, Rosic-Kablar S, Liu J, Jolicoeur P, Dube ID, et al. Dysregulated expression of mitotic regulators is associated with B-cell lymphomagenesis in HOX11-transgenic mice. Oncogene 2006; January 9 [Epub ahead of print].
73. Chieffi P., Cozzolino L., Kisslinger A., Libertini S., Staibano S., Mansueto G., et al. Tramontano D Aurora B expression directly correlates with prostate cancer malignancy and influence prostate cell proliferation. Prostate 66 (2006) 326-333
74. Shen K.C., Heng H., Wang Y., Lu S., Liu G., Deng C.X., et al. ATM and p21 cooperate to suppress aneuploidy and subsequent tumor development. Cancer Res 65 (2005) 8747-8753
75. Damelin M., Sun Y.E., Sodja V.B., and Bestor T.H. Decatenation checkpoint deficiency in stem and progenitor cells. Cancer Cell 8 (2005) 479-484
76. Ro S., and Rannala B. Methylation patterns and mathematical models reveal dynamics of stem cell turnover in the human colon. Proc Natl Acad Sci USA 98 (2001) 10519-10521
77. Kim J.Y., Tavare S., and Shibata D. Counting human somatic cell replications: methylation mirrors endometrial stem cell divisions. Proc Natl Acad Sci USA 102 (2005) 17739-17744
78. Greaves L.C., Preston S.L., Tadrous P.J., Taylor R.W., Barron M.J., Oukrif D., et al. Mitochondrial DNA mutations are established in human colonic stem cells, and mutated clones expand by crypt fission. Proc Natl Acad Sci USA 103 (2006) 714-719
79. Coller H.A., Khrapko K., Herrero-Jimenez P., Vatland J.A., Li-Sucholeiki X.C., and Thilly W.G. Clustering of mutant mitochondrial DNA copies suggests stem cells are common in human bronchial epithelium. Mutat Res 578 (2005) 256-271
80. Nekhaeva E., Bodyak N.D., Kraytsberg Y., McGrath S.B., Van Orsouw N.J., Pluzhnikov A., et al. Clonally expanded mtDNA point mutations are abundant in individual cells of human tissues. Proc Natl Acad Sci USA 99 (2002) 5521-5526
81. Issa J.P., Ahuja N., Toyota M., Bronner M.P., and Brentnall T.A. Accelerated age-related CpG island methylation in ulcerative colitis. Cancer Res 61 (2001) 3573-3577
82. Taneja S.S., Ha S., Swenson N.K., Torra I.P., Rome S., Walden P.D., et al. ART-27, an androgen receptor coactivator regulated in prostate development and cancer. J Biol Chem 279 (2004) 13944-13952
83. Shimamura T., Sakamoto M., Ino Y., Shimada K., Kosuge T., Sato Y., et al. Clinicopathological significance of galectin-3 expression in ductal adenocarcinoma of the pancreas. Clin Cancer Res 8 (2002) 2570-2575